|
Status |
Public on Jan 13, 2017 |
Title |
DLD1.MT1sh51 |
Sample type |
RNA |
|
|
Channel 1 |
Source name |
DLD1.MT1sh51
|
Organism |
Homo sapiens |
Characteristics |
cell type: colorectal cancer cells treatment: DNMT1 shRNA#51 knockdown cell line: DLD1
|
Growth protocol |
standard as recommended by ATCC
|
Extracted molecule |
total RNA |
Extraction protocol |
Trizol method
|
Label |
Cy5
|
Label protocol |
standard as recommended by Agilent
|
|
|
Channel 2 |
Source name |
DLD1
|
Organism |
Homo sapiens |
Characteristics |
cell type: colorectal cancer cells cell line: DLD1 treatment: non-silencing control
|
Growth protocol |
standard as recommended by ATCC
|
Extracted molecule |
total RNA |
Extraction protocol |
Trizol method
|
Label |
Cy3
|
Label protocol |
standard as recommended by Agilent
|
|
|
|
Hybridization protocol |
standard as recommended by Agilent
|
Scan protocol |
standard as recommended by Agilent
|
Description |
DNMT1 shRNA#51 knockdown in DLD1 cells
|
Data processing |
Data were normalized using loess and aquantile methods as described in the Bioconductor limma package
|
|
|
Submission date |
Jan 04, 2017 |
Last update date |
Jan 13, 2017 |
Contact name |
Stephen B Baylin |
E-mail(s) |
[email protected]
|
Organization name |
Johns Hopkins University
|
Street address |
1650 Orleans St. Suite 541
|
City |
Baltimore |
State/province |
MD |
ZIP/Postal code |
21209 |
Country |
USA |
|
|
Platform ID |
GPL6480 |
Series (2) |
GSE93136 |
Cancer cells with genetic disruption of DNA methyltransferases |
GSE93142 |
Gene expression profiling of cancer cells with genetic disruption of DNA methyltransferases [Agilent-014850] |
|